Share Facebook Twitter Email Telegram WhatsApp Death in CRISPR gene therapy study sparks furor… (Third column, 12th story, link…Read More
New treatment for moderate to severe atopic dermatitis shows promising long-term resultsJanuary 29, 2023
Datopotamab deruxtecan showed promising responses as monotherapy and in combination with Imfinzi | Mirage NewsJanuary 29, 2023
